Related Experiment Video
Updated: Feb 21, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
The effect of aspirin on kidney allograft outcomes; a short review to current studies
Wisit Cheungpasitporn1, Charat Thongprayoon1, Donald G Mitema1
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Insights
Aspirin use in kidney transplant recipients significantly lowers the risk of allograft failure, thrombosis, and major adverse cardiac events or mortality. However, it does not impact allograft rejection or delayed graft function, and bleeding risks require further study.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Aspirin use in chronic kidney disease (CKD) patients is linked to reduced myocardial infarction but increased bleeding risk.
- The specific impact of aspirin on kidney transplant recipients remains unclear.
Purpose of the Study:
- To evaluate the efficacy and safety of aspirin in kidney transplant recipients.
- To assess aspirin's effects on allograft outcomes, major adverse cardiac events (MACEs), mortality, and bleeding risk.
Main Methods:
- A comprehensive literature search was conducted across major databases (MEDLINE, EMBASE, Cochrane) up to September 2016.
- Included studies reported risk ratios or hazard ratios for aspirin use in kidney transplant recipients.
- Pooled risk ratios (RR) with 95% confidence intervals (CI) were calculated using a random-effect model.
Main Results:
- The meta-analysis included 9 studies with 19,759 kidney transplant recipients.
- Aspirin significantly reduced the risk of allograft failure (RR: 0.57), allograft thrombosis (RR: 0.11), and MACEs or mortality (RR: 0.72).
- No significant effect was observed on allograft rejection (RR: 0.86) or delayed graft function (DGF) (RR: 1.00); bleeding risk data were limited.
Conclusions:
- Aspirin administration in kidney transplant recipients is associated with decreased risks of allograft failure, thrombosis, and MACEs/mortality.
- Aspirin does not appear to affect allograft rejection or DGF.
- Further research is necessary to fully evaluate bleeding risks and establish the overall risk-benefit profile of aspirin in this population.
Context:
The use of aspirin in chronic kidney disease (CKD) patients has been shown to reduce myocardial infarction but may increase major bleeding. However, its effects in kidney transplant recipients are unclear.
Evidence Acquisitions:
A literature search was performed using MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews from inception through September 2016. We included studies that reported odd ratios, relative risks or hazard ratios comparing outcomes of aspirin use in kidney transplant recipients. Pooled risk ratios (RR) and 95% confidence interval (CI) were assessed using a random-effect, generic inverse variance method.
Results:
We included 9 studies; enrolling 19759 kidney transplant recipients that compared aspirin with no treatment. Compared to no treatment, aspirin reduced the risk of allograft failure (4 studies; RR: 0.57, 95% CI: 0.33 to 0.99), allograft thrombosis (2 studies; RR: 0.11, 95% CI: 0.02 to 0.53), and major adverse cardiac events (MACEs) or mortality (2 studies; RR: 0.72, 95% CI: 0.59 to 0.88), but not allograft rejection (3 studies; RR: 0.86, 95% CI: 0.45 to 1.65) or delayed graft function (DGF) (2 studies; RR: 1.00, 95% CI: 0.58 to 1.72) in kidney transplant recipients. The data on risk of major or minor bleeding were limited.
Conclusions:
Our meta-analysis demonstrates that administration of aspirin in kidney transplant recipients is associated with reduced risks of allograft failure, allograft thrombosis, and MACEs or mortality, but not allograft rejection or DGF. Future studies are needed to assess the risk of bleeding, and ultimately weigh the overall risks and benefits of aspirin use in specific kidney transplant patient populations.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction

